Ischemic stroke
Conditions
Interventions
Aspirin antiplatelet therapy group:None
Clopidogrel antiplatelet therapy group:None
Aspirin clopidogrel dual antiplatelet therapy group:None
Sponsors
Sichuan Academy of Medical Sciences & Sichuan Provice People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Aged 18-80 years; 2.Patients WHO meet the WHO definition of stroke and have non-cardiogenic cerebral infarction confirmed by head CT or MRI; 3.Aspirin and/or clopidogrel antiplatelet drugs for 6-8 days; 4. First onset, the time from onset to admission<=2 weeks; 5.NIHSS score < 15; 6.Informed consent was obtained from patients or their families.
Exclusion criteria
Exclusion criteria: 1.Age 80 years old; 2.Previous medical history/dynamic electrocardiogram/echocardiography/foam test suggested cardiogenic cerebral infarction caused by atrial fibrillation/valvular heart disease/patent foramen ovale, etc. 3.Patients receiving thrombolysis/thrombectomy/stent therapy; 4.Patients taking anticoagulant drugs; 5.Contraindication or intolerance to antiplatelet therapy; 6.Patients with poor compliance and inability to cooperate with the research requirements; 7.Patients or family members refused to sign informed consent forms.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet aggregation function;Major ischemic events (ischemic cerebrovascular disease, ischemic cardiovascular disease, peripheral arterial disease, etc.);Major hemorrhagic event (bleeding from the Alliance for Academic Research of Bleeding (BARC) grade 2 or higher); | — |
Secondary
| Measure | Time frame |
|---|---|
| Death or disability; | — |
Countries
China
Contacts
Public ContactYang Jie
Sichuan Academy of Medical Sciences & Sichuan Provice People's Hospital
Outcome results
None listed